Beihai Gofar Marine Biological Industry Co Ltd (600538) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.30 Million ≈ $-1.51 Million USD) by net assets (CN¥785.32 Million ≈ $114.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Beihai Gofar Marine Biological Industry to measure how much of total assets are equity-financed.
Beihai Gofar Marine Biological Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600538 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Source Capital Closed Fund
NYSE:SOR
|
-0.093x |
|
Swedencare publ AB
ST:SECARE
|
0.007x |
|
Immobiliere Dassault SA
PA:IMDA
|
0.022x |
|
IGB Commercial Real Estate Investment Trust Unit
KLSE:5299
|
0.074x |
|
Kolte - Patil Developers Limited
NSE:KOLTEPATIL
|
0.136x |
|
Doright Co.Ltd.
SHE:300950
|
-0.007x |
|
Aurora Corp
TW:2373
|
-0.013x |
|
Korea Petro Chemical Ind
KO:006650
|
0.012x |
Annual Cash Flow Conversion Efficiency for Beihai Gofar Marine Biological Industry Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Beihai Gofar Marine Biological Industry Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Beihai Gofar Marine Biological Industry stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥700.78 Million ≈ $102.55 Million |
CN¥-13.40 Million ≈ $-1.96 Million |
-0.019x | -872.57% |
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
CN¥1.95 Million ≈ $285.10K |
0.002x | +112.11% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
CN¥-17.97 Million ≈ $-2.63 Million |
-0.020x | -24.61% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
CN¥-15.74 Million ≈ $-2.30 Million |
-0.016x | -138.70% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
CN¥-6.34 Million ≈ $-927.46K |
-0.007x | -121.79% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
CN¥26.84 Million ≈ $3.93 Million |
0.032x | +473.92% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
CN¥-5.44 Million ≈ $-796.48K |
-0.008x | +84.07% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
CN¥-33.75 Million ≈ $-4.94 Million |
-0.053x | -196.61% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥36.12 Million ≈ $5.29 Million |
0.055x | +302.99% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.027x | -204.70% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
CN¥-6.54 Million ≈ $-956.52K |
-0.009x | +84.25% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
CN¥-41.05 Million ≈ $-6.01 Million |
-0.056x | -26.81% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
CN¥-4.95 Million ≈ $-724.11K |
-0.044x | +83.13% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
CN¥-24.09 Million ≈ $-3.52 Million |
-0.263x | -215.90% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
CN¥-15.95 Million ≈ $-2.33 Million |
-0.083x | -27.56% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
CN¥-14.71 Million ≈ $-2.15 Million |
-0.065x | -514.62% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
CN¥-2.20 Million ≈ $-322.18K |
-0.011x | -119.93% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
CN¥17.34 Million ≈ $2.54 Million |
0.053x | -38.36% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
CN¥42.60 Million ≈ $6.23 Million |
0.086x | -51.04% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
CN¥93.45 Million ≈ $13.67 Million |
0.177x | +3215.25% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
CN¥2.94 Million ≈ $429.53K |
0.005x | -53.20% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
CN¥5.94 Million ≈ $869.21K |
0.011x | +1364.46% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
CN¥-430.83K ≈ $-63.04K |
-0.001x | -100.78% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
CN¥17.01 Million ≈ $2.49 Million |
0.115x | -35.72% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
CN¥23.35 Million ≈ $3.42 Million |
0.179x | -- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more